Drug Pipeline

Selexipag Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
2
Phase 3
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing…
date change Completion pushed: 2029-03-30 -> 2030-09-30
Active Studies by Phase
Phase 4
1
Phase 3
2
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05825417 Pulmonary Hypertension: Intensification and Personalisation of Combination Rx Pulmonary Arterial Hypertension Recruiting
Phase 3
NCT05179876 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing… Hypertension, Pulmonary Recruiting
NCT04175600 A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary… Hypertension, Pulmonary Active, Not Recruiting
Phase 2
NCT03492177 A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial… Pulmonary Arterial Hypertension Active, Not Recruiting
Not specified
NCT07356375 Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral… Pulmonary Arterial Hypertension (PAH) Not Yet Recruiting
Sponsors Running Selexipag Trials
Disease Areas
Get alerts when Selexipag trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free